Abstract

High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products

Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy

Issue: Nov/Dec 2014 - Volume 18, Number 6

Page(s): 520-525

Download in electronic PDF format for $75
  • High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 1
  • High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 2
  • High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 3
  • High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 4
  • High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 5
  • High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Page 6

Abstract

The compounding and evaluation of ondansetron hydrochloride dihydrate topical gel, 2.5% w/w, were conducted in this study. The gelling agent was Carbopol 940. Ethanol 70% in purified water was used to dissolve the drug and disperse the gelling agent. A gel was formed by adding drops of 0.1 N sodium hydroxide solution. To assay this gel, we developed a simple and reproducible stabilityindicating high-performance liquid chromatographic method. This method was validated for specificity, accuracy, and precision. The compounded gel was assayed in triplicate, and the average recovery was 98.3%. Ondansetron marketed products were analyzed for comparison with the compounded formulation. Assay, accuracy, and precision data of the compounded topical gel were comparable to the marketed products.

Related Keywords

  • ondansetron hydrochloride dihydrate
  • topical preparations
  • Carbopol 940
  • antiemetic
  • nausea
  • vomiting
  • serotonin 5-HT3 receptor antagonist
  • 5-HT3 blocker
  • formulations
  • HPLC assay development

Related Categories

  • CANCER AND AIDS
  • EXCIPIENTS
  • PEER-REVIEWED
  • QUALITY CONTROL
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2014
Pg. 520-525
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
May/Jun 2004
Pg. 223-227
Quality-Control Analytical Methods: High-Performance Liquid Chromatography
Author(s): Kupiec Thomas C
Jul/Aug 2012
Pg. 339
Ondansetron Hydrochloride 2-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 164-170
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Author(s): Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
Jan/Feb 2020
Pg. 60
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jul/Aug 2001
Pg. 320-322
A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes
Author(s): Abang Anthony M, Abbas S Ali, Pham Trinh, Lambros Maria Polikandritou
Jul/Aug 2000
Pg. 250-251
Nausea and Vomiting in Hospice Patients
Author(s): Boomsma Diane
Mar/Apr 2007
Pg. 158
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2006
Pg. 95-98
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Author(s): Moon Richard B
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Jul/Aug 1999
Pg. 314-315
Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography
Author(s): Gupta Vishnu D, Pramar Y
Mar/Apr 1999
Pg. 158-159
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography
Author(s): Gupta Vishnu D
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jan/Feb 1998
Pg. 83-88
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane
Author(s): Tenjarla Srini N, Ward Earl S, Fox Janet L
Sep/Oct 2003
Pg. 389-393
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Author(s): Alexander Kenneth S, Thyangarajapuram N
Mar/Apr 2008
Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Jan/Feb 2016
Pg. 63-70
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation
Author(s): Hergert Lisandro Y, Ravetti Soledad, Mazzieri Maria R
Jan/Feb 2013
Pg. 66
Granisetron 1-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 238-241
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Xu Quanyun A